메뉴 건너뛰기




Volumn 45, Issue 6, 2013, Pages 438-445

Impact of a hospital-wide antibiotic restriction policy program on the resistance rates of nosocomial Gram-negative bacteria

Author keywords

Antibiotic consumption; Antibiotic policies; Antibiotic restriction; Gram negatives; Microbial resistance

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MACROLIDE; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM;

EID: 84877904362     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2012.760845     Document Type: Article
Times cited : (13)

References (23)
  • 1
    • 84857646835 scopus 로고    scopus 로고
    • Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard defi nitions for acquired resistance
    • Magiorakos AP, S rinivasan A, C arey RB, C armeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard defi nitions for acquired resistance. Clin Microbiol Infect 2012; 18: 268-81.
    • (2012) Clin Microbiol Infect , vol.18 , pp. 268-281
    • Magiorakos, A.P.1    Srinivasan, A.2    Carey, R.B.3    Carmeli, Y.4    Falagas, M.E.5    Giske, C.G.6
  • 2
    • 70349739265 scopus 로고    scopus 로고
    • The clinical consequences of antimicrobial resistance
    • Rice LB. The clinical consequences of antimicrobial resistance. Curr Opin Microbiol 2009; 12: 476-81.
    • (2009) Curr Opin Microbiol , vol.12 , pp. 476-481
    • Rice, L.B.1
  • 4
    • 67651112200 scopus 로고    scopus 로고
    • Antimicrobial use: Risk driver of multidrug resistant microorganisms in healthcare settings
    • Taconelli E. A ntimicrobial use: Risk driver of multidrug resistant microorganisms in healthcare settings. Curr Opin Infect Dis 2009; 22: 352-8.
    • (2009) Curr Opin Infect Dis , vol.22 , pp. 352-358
    • Taconelli, E.1
  • 5
    • 48449087731 scopus 로고    scopus 로고
    • The withdrawal of antimicrobial treatment as a mechanism for defeating resistant microorganisms
    • Stokes D J, K elly A F, G ould S W, C assar C A, F ielder M D. The withdrawal of antimicrobial treatment as a mechanism for defeating resistant microorganisms. FEMS Immunol Med Microbiol 2008; 53: 300-5.
    • (2008) FEMS Immunol Med Microbiol , vol.53 , pp. 300-305
    • Stokes, D.J.1    Kelly, A.F.2    Gould, S.W.3    Cassar, C.A.4    Fielder M, D.5
  • 6
    • 33846153776 scopus 로고    scopus 로고
    • Infectious diseases society of america and the society for healthcare epidemiology of america guidelines for developing an institutional program to enhance antimicrobial stewardship
    • Dellit T H, O wens RC, M cGowan JE, G erding DN, Weinstein RA, Burke JP, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007; 44: 159-77.
    • (2007) Clin Infect Dis , vol.44 , pp. 159-177
    • Dellit, T.H.1    Owens, R.C.2    McGowan, J.E.3    Gerding, D.N.4    Weinstein, R.A.5    Burke, J.P.6
  • 9
    • 84877895269 scopus 로고    scopus 로고
    • Available at: European Centre for Disease Control and Prevention (ECDC), (accessed 5 December 2012
    • European Centre for Disease Control and Prevention (ECDC), European Surveillance of Antimicrobial Concumption Network (ESAC-Net) 2011. Available at: http:// www.ecdc.europa.eu/en/activities/surveillance/ESAC-net (accessed 5 December 2012
    • (2011) European Surveillance of Antimicrobial Concumption Network (ESAC-Net
  • 10
    • 27144499116 scopus 로고    scopus 로고
    • Performance standards for antimicrobial susceptibility testing
    • Clinical and Laboratory Standards Institute. Wayne, PA: CLSI
    • Clinical and Laboratory Standards Institute. P erformance standards for antimicrobial susceptibility testing. Fifteenth informational supplement. M100-S15. Wayne, PA: CLSI ; 2005.
    • (2005) Fifteenth informational supplement
  • 11
    • 0242437868 scopus 로고    scopus 로고
    • Room for improvement: A systematic review of the quality of evaluations of interventions to improve hospital antibiotic prescribing
    • Ramsay C, B rown E, H artman G, D avey P. R oom for improvement: A systematic review of the quality of evaluations of interventions to improve hospital antibiotic prescribing. J Antimicrob Chemother 2003; 52: 764-7.
    • (2003) J Antimicrob Chemother , vol.52 , pp. 764-767
    • Ramsay, C.1    Brown, E.2    Hartman, G.3    Davey, P.4
  • 12
    • 0242521391 scopus 로고    scopus 로고
    • Outcomes of an intervention to improve hospital antibiotic prescribing: Interrupted time series with segmented regression analysis
    • Ansari F, G ray K, N athwani D, P hillips G, O gston S, Ramsay C, et al. Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis. J Antimicrob Chemother 2003; 52: 842-8.
    • (2003) J Antimicrob Chemother , vol.52 , pp. 842-848
    • Ansari, F.1    Gray, K.2    Nathwani, D.3    Phillips, G.4    Ogston, S.5    Ramsay, C.6
  • 13
    • 33845646294 scopus 로고    scopus 로고
    • Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospital
    • Petrikkos G, M arkogiannakis A, P apapareskevas J, D aikos GL, Stefanakos G, Zissis NP, et al. Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospital. Int J Antimicrob Agents 2007; 29: 34-8.
    • (2007) Int J Antimicrob Agents , vol.29 , pp. 34-38
    • Petrikkos, G.1    Markogiannakis, A.2    Papapareskevas, J.3    Daikos, G.L.4    Stefanakos, G.5    Zissis, N.P.6
  • 14
    • 34548141837 scopus 로고    scopus 로고
    • Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children ' s hospital by changing antimicrobial agent usage policy
    • Lee J, P ai H, K im Y K, K im N H, E un B W, K ang HJ, et al. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children ' s hospital by changing antimicrobial agent usage policy. J Antimicrob Chemother 2007; 60: 629-37.
    • (2007) J Antimicrob Chemother , vol.60 , pp. 629-637
    • Lee, J.1    Pai, H.2    Kim, Y.K.3    Kim, N.H.4    Eun, B.W.5    Kang, H.J.6
  • 16
    • 0034888089 scopus 로고    scopus 로고
    • Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center
    • Solomon DH, V an Houten L, G lynn RJ. A cademic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch Intern Med 2001; 161: 1897-902.
    • (2001) Arch Intern Med , vol.161 , pp. 1897-1902
    • Solomon, D.H.1    Van Houten, L.2    Glynn, R.J.3
  • 17
    • 47249156875 scopus 로고    scopus 로고
    • Control of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae using a computer-assisted management program to restrict third-generation cephalosporin use
    • Kim J Y, S ohn J W, P ark D W, Y oon Y K, K im Y M, K im M J. Control of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae using a computer-assisted management program to restrict third-generation cephalosporin use. J Antimicrob Chemother 2008; 62: 416-2.
    • (2008) J Antimicrob Chemother , vol.62 , pp. 416-422
    • Kim, J.Y.1    Sohn, J.W.2    Park, D.W.3    Yoon, Y.K.4    Kim, Y.M.5    Kim M, J.6
  • 19
    • 66149118585 scopus 로고    scopus 로고
    • Relationship of carbapenem restriction in 22 university teaching hospitals to carbapenem use and carbapenem-resistant pseudomonas aeruginosa
    • Pakyz A L, O inonen M, P olk RE. R elationship of carbapenem restriction in 22 University teaching hospitals to carbapenem use and carbapenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 2009; 53: 1983-6.
    • (2009) Antimicrob Agents Chemother , vol.53 , pp. 1983-1986
    • Pakyz, A.L.1    Oinonen, M.2    Polk, R.E.3
  • 20
    • 34548380755 scopus 로고    scopus 로고
    • Impact of an antibiotic restriction policy on the antibiotic resistance patterns of Gram-negative microorganisms in an intensive care unit in Greece
    • Ntagiopoulos P, P aramythiotou E, A ntoniadou A, G iamarellou H, Karabinis A. Impact of an antibiotic restriction policy on the antibiotic resistance patterns of Gram-negative microorganisms in an intensive care unit in Greece. Int J Antimicrob Agents 2007; 30: 360-5.
    • (2007) Int J Antimicrob Agents , vol.30 , pp. 360-365
    • Ntagiopoulos, P.1    Paramythiotou, E.2    Antoniadou, A.3    Giamarellou, H.4    Karabinis, A.5
  • 21
    • 0032517251 scopus 로고    scopus 로고
    • Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella
    • Rahal J J, U rban C, H orn D, F reeman K, S egal-Maurer S, Maurer J, et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 1998; 280: 1233-7.
    • (1998) JAMA , vol.280 , pp. 1233-1237
    • Rahal, J.J.1    Urban, C.2    Horn, D.3    Freeman, K.4    Segal-Maurer, S.5    Maurer, J.6
  • 22
    • 0033665995 scopus 로고    scopus 로고
    • Influence of an infectious disease service on antibiotic prescription behavior and selection of multiresistant pathogens
    • Lemmen SW, H ä f ner H, K otterik S, L ü tticken R, T öp per R. Infl uence of an infectious disease service on antibiotic prescription behavior and selection of multiresistant pathogens. Infection 2000; 28: 384-7.
    • (2000) Infection , vol.28 , pp. 384-387
    • Lemmen, S.W.1    Häfner, H.2    Kotterik, S.3    Lütticken, R.4    Töpper, R.5
  • 23
    • 0042267326 scopus 로고    scopus 로고
    • Ahospitalwide intervention program to optimize the quality of antibiotic use: Impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance
    • Bantar C, S artori B, V esco E, H eft C, S aul M, S alamone F, Oliva ME. A hospitalwide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance. Clin Infect Dis 2003; 37: 180-6.
    • (2003) Clin Infect Dis , vol.37 , pp. 180-186
    • Bantar, C.1    Sartori, B.2    Vesco, E.3    Heft, C.4    Saul, M.5    Salamone, F.6    Oliva, M.E.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.